➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Colorcon
McKinsey
Dow
AstraZeneca
Express Scripts

Last Updated: February 26, 2021

DrugPatentWatch Database Preview

Thioridazine hydrochloride - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for thioridazine hydrochloride and what is the scope of patent protection?

Thioridazine hydrochloride is the generic ingredient in three branded drugs marketed by Novartis, Actavis Mid Atlantic, Akorn, Alpharma Us Pharms, Ani Pharms Inc, Pharm Assoc, Sandoz, Wockhardt, Roxane, Fosun Pharma, Heritage Pharma, Mutual Pharm, Mylan, Par Pharm, Sun Pharm Industries, Superpharm, Watson Labs, Watson Labs Teva, and West Ward, and is included in eighty NDAs. Additional information is available in the individual branded drug profile pages.

There are eighteen drug master file entries for thioridazine hydrochloride. Four suppliers are listed for this compound.

Recent Clinical Trials for thioridazine hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Rabin Medical CenterEarly Phase 1
Rambam Health Care CampusEarly Phase 1
Astellas Pharma IncPhase 4

See all thioridazine hydrochloride clinical trials

Pharmacology for thioridazine hydrochloride
Drug ClassPhenothiazine

US Patents and Regulatory Information for thioridazine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Heritage Pharma THIORIDAZINE HYDROCHLORIDE thioridazine hydrochloride TABLET;ORAL 088479-001 Nov 8, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
West Ward THIORIDAZINE HYDROCHLORIDE thioridazine hydrochloride TABLET;ORAL 088658-001 Mar 26, 1984 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs THIORIDAZINE HYDROCHLORIDE thioridazine hydrochloride TABLET;ORAL 088323-001 Jul 28, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
Sun Pharm Industries THIORIDAZINE HYDROCHLORIDE thioridazine hydrochloride TABLET;ORAL 089953-004 Aug 1, 1986 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
McKesson
Harvard Business School
Moodys
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.